US20220295713A1 - Plant activator and a method of manufacturing the same - Google Patents
Plant activator and a method of manufacturing the same Download PDFInfo
- Publication number
- US20220295713A1 US20220295713A1 US17/832,837 US202217832837A US2022295713A1 US 20220295713 A1 US20220295713 A1 US 20220295713A1 US 202217832837 A US202217832837 A US 202217832837A US 2022295713 A1 US2022295713 A1 US 2022295713A1
- Authority
- US
- United States
- Prior art keywords
- fatty acid
- plant activator
- plant
- acid
- metabolism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000005962 plant activator Substances 0.000 title claims abstract description 115
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 82
- 239000000194 fatty acid Substances 0.000 claims abstract description 82
- 229930195729 fatty acid Natural products 0.000 claims abstract description 82
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 81
- 238000000034 method Methods 0.000 claims abstract description 32
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 30
- 239000001301 oxygen Substances 0.000 claims abstract description 30
- 230000004129 fatty acid metabolism Effects 0.000 claims abstract description 26
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 19
- 230000001939 inductive effect Effects 0.000 claims abstract description 19
- 230000004060 metabolic process Effects 0.000 claims abstract description 18
- 239000002207 metabolite Substances 0.000 claims abstract description 17
- 241001135756 Alphaproteobacteria Species 0.000 claims abstract description 10
- 201000010099 disease Diseases 0.000 claims description 38
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 38
- 239000003795 chemical substances by application Substances 0.000 claims description 29
- 241000192142 Proteobacteria Species 0.000 claims description 22
- 239000003876 biosurfactant Substances 0.000 claims description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 9
- 239000011707 mineral Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 230000000069 prophylactic effect Effects 0.000 claims description 4
- 239000002689 soil Substances 0.000 abstract description 17
- 238000011109 contamination Methods 0.000 abstract description 8
- 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 abstract description 7
- 231100000053 low toxicity Toxicity 0.000 abstract description 6
- 241000196324 Embryophyta Species 0.000 description 44
- 239000000243 solution Substances 0.000 description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 230000000052 comparative effect Effects 0.000 description 21
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 20
- 230000001404 mediated effect Effects 0.000 description 18
- 230000019491 signal transduction Effects 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 17
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 15
- 240000003768 Solanum lycopersicum Species 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 15
- 230000006378 damage Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 230000012010 growth Effects 0.000 description 14
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 238000012258 culturing Methods 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 10
- 235000020778 linoleic acid Nutrition 0.000 description 10
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 10
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 10
- 229960004889 salicylic acid Drugs 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 231100000208 phytotoxic Toxicity 0.000 description 9
- 230000000885 phytotoxic effect Effects 0.000 description 9
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 8
- 244000061458 Solanum melongena Species 0.000 description 8
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 8
- 238000005507 spraying Methods 0.000 description 8
- 235000004789 Rosa xanthina Nutrition 0.000 description 7
- 241000109329 Rosa xanthina Species 0.000 description 7
- 235000002597 Solanum melongena Nutrition 0.000 description 7
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 7
- 244000052616 bacterial pathogen Species 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000219195 Arabidopsis thaliana Species 0.000 description 6
- 229930195482 Validamycin Natural products 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 239000003337 fertilizer Substances 0.000 description 6
- WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 6
- 230000008635 plant growth Effects 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 6
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 5
- 240000008067 Cucumis sativus Species 0.000 description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 5
- 230000035784 germination Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 4
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 4
- 229960004488 linolenic acid Drugs 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 241000221785 Erysiphales Species 0.000 description 3
- 102000003820 Lipoxygenases Human genes 0.000 description 3
- 108090000128 Lipoxygenases Proteins 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 241001148470 aerobic bacillus Species 0.000 description 3
- 239000003905 agrochemical Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000006806 disease prevention Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 3
- 229960002733 gamolenic acid Drugs 0.000 description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- -1 linoleic acid peroxide Chemical class 0.000 description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 3
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000021313 oleic acid Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- UNSRRHDPHVZAHH-YOILPLPUSA-N (5Z,8Z,11Z)-icosatrienoic acid Chemical compound CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(O)=O UNSRRHDPHVZAHH-YOILPLPUSA-N 0.000 description 2
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 2
- UNSRRHDPHVZAHH-UHFFFAOYSA-N 6beta,11alpha-Dihydroxy-3alpha,5alpha-cyclopregnan-20-on Natural products CCCCCCCCC=CCC=CCC=CCCCC(O)=O UNSRRHDPHVZAHH-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000123650 Botrytis cinerea Species 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 239000005805 Mepanipyrim Substances 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 235000021322 Vaccenic acid Nutrition 0.000 description 2
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 2
- 108060000307 allene oxide cyclase Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 2
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- JDSRHVWSAMTSSN-IRQZEAMPSA-N 13(S)-HPODE Chemical compound CCCCC[C@H](OO)\C=C\C=C/CCCCCCCC(O)=O JDSRHVWSAMTSSN-IRQZEAMPSA-N 0.000 description 1
- JDSRHVWSAMTSSN-BSZOFBHHSA-N 13-HPODE Chemical compound CCCCCC(OO)\C=C\C=C/CCCCCCCC(O)=O JDSRHVWSAMTSSN-BSZOFBHHSA-N 0.000 description 1
- KNDAEDDIIQYRHY-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(piperazin-1-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCNCC1 KNDAEDDIIQYRHY-UHFFFAOYSA-N 0.000 description 1
- JGUNZIWGNMQSBM-UINYOVNOSA-N 9(S)-HPODE Chemical compound CCCCC\C=C/C=C/[C@@H](OO)CCCCCCCC(O)=O JGUNZIWGNMQSBM-UINYOVNOSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- JGUNZIWGNMQSBM-SIGMCMEVSA-N E,E-9-HpODE Chemical compound CCCCC\C=C\C=C\C(OO)CCCCCCCC(O)=O JGUNZIWGNMQSBM-SIGMCMEVSA-N 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- 101150054548 PR1 gene Proteins 0.000 description 1
- 241000588702 Pectobacterium carotovorum subsp. carotovorum Species 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004274 Sarcandra glabra Species 0.000 description 1
- 235000010842 Sarcandra glabra Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000000099 Solanum integrifolium Nutrition 0.000 description 1
- 244000244100 Solanum integrifolium Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- PASOAYSIZAJOCT-UHFFFAOYSA-N butanoic acid Chemical compound CCCC(O)=O.CCCC(O)=O PASOAYSIZAJOCT-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 101150060629 def gene Proteins 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003895 organic fertilizer Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 101150096397 pdf1 gene Proteins 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000028624 response to insect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000021918 systemic acquired resistance Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G7/00—Botany in general
- A01G7/06—Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05F—ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE
- C05F11/00—Other organic fertilisers
- C05F11/08—Organic fertilisers containing added bacterial cultures, mycelia or the like
Definitions
- the present invention relates to a plant activator and a method of manufacturing the same.
- a growth promotion using a plant activator having, for example, a plant growth control activity such as growth promotion (which refers to the concept that includes an enlargement of leaves and stems and a growth promotion of tubers and tuberous roots), sleep suppression, imparting a stress resistance to plant, and anti-aging.
- a plant growth control activity such as growth promotion (which refers to the concept that includes an enlargement of leaves and stems and a growth promotion of tubers and tuberous roots), sleep suppression, imparting a stress resistance to plant, and anti-aging.
- Reference 1 describes a plant activator comprising a ketol fatty acid with 4 to 24 carbon atoms as an active ingredient.
- the plant disease and insect pest control depends largely on synthesized agrochemicals, however, in view of the soil contamination as well as human health damage, reducing the amount of the agrochemical to be used has been required.
- Some measures using a disease resistance inducing agent are known as a method for controlling a plant disease or pests to protect plants without using agrochemicals.
- resistance inducing agents include, for example, probenazole, isotianil, acibenzolar-S-methyl (ASM), 3′-chloro-4,4′-dimethyl-1,2,3-thiadiazole-5-carboxianilide (tiadinil), and Validamycin.
- Patent Document 1 The effect of the plant activator disclosed in Patent Document 1 is still not enough, and the plant activator having a better activation effect is in need.
- the conventional resistance-inducing agents are chemically synthesized, so that their toxicities are extremely high.
- Aforementioned agents including probenazole, isotianil, acibenzolar-S-methyl (ASM), 3′-chloro-4,4′-dimethyl-1,2,3-thiadiazole-5-carboxianilide (tiadinil) may induce the systemic acquired resistance that is activated through the salicylic acid and induced by the exposure to elicitors such as pathogenic bacteria and viruses (salicylic acid mediated signaling pathway), but does not induce the resistance to be activated thorough the jasmonic acid (and ethylene) that is synthesized in response to insect herbivory or insect injury (jasmonate mediated signaling pathway).
- Patent Document 2 discloses the use of chemically synthesized linoleic acid peroxide as a plant growth regulator, however, it did not exhibit enough efficacy in preventing disease damage.
- the fatty acid oxide including a peroxylipid exhibits antibacterial activity. It has also been known that a jasmonic acid, for example, is biosynthezised in plants from fatty acid such as linolenic acid. However, it is not known that metabolites from fatty acid oxidation by microbial metabolization process have resistance-inducing activity.
- resistance-inducing agents and peroxylipids are only very slightly water soluble, and thus, one would normally have to use strong emulsifiers or dispersants when using them for treatment.
- the present invention relates to a plant activator comprising a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- the fatty acid is a liquid fatty acid at a temperature of 20° C.
- the proteobacteria is a proteobacteria that has been pre-cultured to 1 ⁇ 10 8 to 9 ⁇ 10 10 cells/mL.
- the metabolism is a metabolism in the presence of at least one type of mineral selected from Mg, P, Na and K.
- the plant activator comprises a biosurfactant.
- the metabolism is a metabolism under a condition of temperature from 10 to 40° C.
- the plant activator serves as a resistance-inducing agent.
- the plant activator serves as a prophylactic agent for a wilt disease in solanaceous plants.
- the present invention relates to a method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- the method for manufacturing a plant activator it may be preferable for the method for manufacturing a plant activator that the fatty acid is liquid at a temperature of 20° C.
- the method for manufacturing a plant activator it may be preferable for the method for manufacturing a plant activator that the proteobacteria has been pre-cultured to 1 ⁇ 10 8 to 9 ⁇ 10 10 cells/mL.
- the method for manufacturing a plant activator comprises the step for fatty acid metabolism performed in the presence of at least one type of mineral selected from Mg, P, Na and K.
- the method for manufacturing a plant activator comprises a biosurfactant.
- the method for manufacturing a plant activator comprises the step for fatty acid metabolism performed under a condition of temperature from 10 to 40° C.
- the method for manufacturing a plant activator may be preferable for the method for manufacturing a plant activator that the plant activator serves as a resistance-inducing agent.
- the plant activator serves as a prophylactic agent for a wilt disease in solanaceous plants.
- the plant activator of the present invention has superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination. Further, according to the method for manufacturing a plant activator of the present invention, the plant activator having superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination can be produced.
- FIG. 1 is a table (formerly “Table 1” in the international phase) that shows test results of the plant activator in an example 1 followed by five comparative examples 1 through 5.
- FIG. 2 is a graph showing a gene expression level in Arabidopsis thaliana.
- FIG. 3 shows a real-time PCR amplification curve of PR1 gene.
- FIG. 4 is a picture showing a result of a growth-promoting activity in eggplant root.
- FIG. 5 is a picture showing a result of a growth-promoting activity in eggplant root.
- a plant activator of the present invention is characterized in that it comprises a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- a fatty acid metabolite of the present invention can render plants resistance and promote plant growth by being sprayed or applied to a plant root, stem or leaf. This may be because the fatty acid metabolite includes a substance or a precursor of the substance that activates the salicylic acid mediated signaling pathway or jasmonate mediated signaling pathway associated with resistance induction. Further, the fatty acid metabolite may also include a substance that activates plant growth, given that plant growth-promoting effect can be seen.
- a metabolism in the context of the present invention involves performing a decomposition or synthesis using a fatty acid with 4 to 30 carbon atoms as a starting material by, for example, enzymes secreted via an endocrine or exocrine pathway by proteobacteria under a predetermined dissolved oxygen concentration.
- Examples include a method for culturing the proteobacteria in a culture media including the fatty acid in the context of the present invention under a predetermined dissolved oxygen concentration.
- the number of carbon atoms in the fatty acid to be used in the present invention is from 4 to 30, preferably 10 to 20.
- the melting point and/or boiling point of the fatty acid is low, so that it tends to become highly volatile at a culture temperature and can hardly remain in the culture media.
- the number of carbon atoms is more than 30, the melting point and/or boiling point of the fatty acid is high, so that it tends to become a solid at a culture temperature and cannot be mixed with a culture media, resulting in the separation of the fatty acid from the culture media.
- the melting point of the fatty acid does not always depend on only the number of carbon atoms based on the number of hydrogen bonds.
- the fatty acid to be used in the present invention is preferably a liquid fatty acid at a temperature from 20 to 30° C. in terms of their metabolism efficiency as well as to prevent solidification in the culture media.
- the fatty acid in the context of the present invention may be either a saturated fatty acid or a unsaturated fatty acid, or a mixture including both fatty acids. Further a vegetable oil, a triglyceride form, or a free fatty acid may be used. Preferably, the fatty acid is a free fatty acid (monocarboxylic acid) in terms of its superior decomposition rate.
- Exemplary examples of free fatty acid with 4 to 30 carbon atoms include for instance, butanoic acid (butyric acid), pentanoic acid (valeric acid), caproic acid, enanthic acid (heptylic acid), caprylic acid, pelargonic acid, capric acid, lauric acid, myristic acid, pentadecylic acid, palmitic acid, palmitoleic acid, margaric acid, stearic acid, oleic acid, vaccenic acid, linoleic acid, ⁇ -linolenic acid, ⁇ -linolenic acid, eleostearic acid, arachidic acid, mead acid, arachidonic acid, behenic acid, lignoceric acid, nervonic acid, cerotic acid, montanic acid, and melissic acid.
- butanoic acid butyric acid
- pentanoic acid valeric acid
- caproic acid enanthic acid
- the fatty acid is a fatty acid which has 10 to 20 carbon atoms such as capric acid, lauric acid, myristic acid, pentadecylic acid, palmitic acid, palmitoleic acid, margaric acid, stearic acid, oleic acid, vaccenic acid, linoleic acid, ⁇ -linolenic acid, ⁇ -linolenic acid, eleostearic acid, arachidic acid, mead acid, or arachidonic acid. More preferably, the fatty acid is a fatty acid which has 18 carbon atoms such as oleic acid, linoleic acid, ⁇ -linolenic acid, or ⁇ -linolenic acid.
- a fatty acid content in the culture media is 100 g/L or less, more preferably 60 g/L or less, still more preferably 12 g/L or less when the culture media containing the fatty acid is used.
- the fatty acid content is over 100 g/L, emulsification of the fatty acid with water in the culture media may become difficult, deteriorating metabolism efficiency or resulting in an inhibition of proteobacteria growth.
- the lower limit of the fatty acid content is not particularly limited, the fatty acid content is preferably 1.0 g/L or more.
- the culture media containing a fatty acid in the context of the present invention also contains a mineral component.
- mineral components include for instance, but not particularly limited to, a mineral component which is used for culturing microorganism. Examples include for instance a component containing magnesium (Mg), phosphorous (P), sodium (Na), or potassium (K). These components can be used alone or in combination.
- a mineral component content in the culture media is not particularly limited, and can be adapted to the content used with a conventional method for culturing an aerobic bacteria.
- a proteobacteria which can be used in the context of the present invention is not particularly limited unless it provides a desirable effect of the present invention.
- the proteobacteria is a proteobacteria which has a suitable growth temperature (an optimum temperature) of from 10 to 40° C., more preferably 20 to 30° C. in terms of its fatty acid metabolism efficiency as well as growth efficiency.
- a proteobacteria in the context of the present invention is a pre-cultured proteobacteria, preferably, to the cell concentration at the end of pre-culture of 1 ⁇ 10 8 to 9 ⁇ 10 10 cells/mL, in such case the proteobacteria can have superior fatty acid metabolism efficiency.
- a dissolved oxygen concentration during metabolism is 0.1 mg/L or more.
- the proteobacteria activity tends to become low, resulting in a significantly low fatty acid metabolism efficiency.
- the dissolved oxygen concentration is 8 mg/L or less, more preferably 5 mg/L or less, still more preferably 3 mg/L or less.
- the dissolved oxygen concentration is over 8 mg/L, the fatty acid tends to be oxidized by oxygen in the culture media, resulting in the reduced plant activation activity.
- dissolved oxygen levels are values detected by using PO electrodes by a diaphragm galvanic electrode method or diaphragm polarographic method using a dissolved oxygen meter from HORIBA, Ltd.
- the temperature during metabolism can be adapted suitably according to the proteobacteria to be used, and is preferably from 10 to 40° C., more preferably from 20 to 30° C. in terms of fatty acid metabolism efficiency.
- the plant activator of the present invention includes a biosurfactant in addition to the fatty acid metabolite, so that the fatty acid as well as the fatty acid metabolite becomes water soluble.
- the biosurfactant according to the present invention is a surfactant produced by proteobacteria.
- the plant activator of the present invention is significantly effective as a resistance-inducing agent and growth promoting agent with a low toxicity and soil contamination.
- the plant activator of the present invention is particularly effective as a resistance-inducing agent compared to the conventional resistance-inducing agents in that the plant activator of the present invention can activate both of respective resistance inductions through a salicylic acid mediated signaling pathway and through a jasmonate mediated signaling pathway. Further, the plant activator of the present invention can activate a resistance induction and plant growth in all parts of the plant by being applied to a part of the plant root, stem or leaf.
- Validamycin which is known as a resistance-inducing agent against wilt disease in solanaceous plants, should not be used in tomatoes, as an exception, because it could cause phytotoxic damage
- the plant activator of the present invention can exhibit a resistance-inducing effect even on the wilt disease in tomatoes without causing any phytotoxic damages.
- the plant activator of the present invention can be widely applied to the plants, regardless of their species.
- the plants include dicotyledonous plants of Cucurbitaceae family or Solanaceae family, and monocotyledonous plants of Gramineae family.
- Methods for application includes, for example, a method of applying or spraying to, for example, a plant root, stem or leaf, and a method of spraying on the soil or watering.
- a method for manufacturing a plant activator containing a fatty acid metabolite of the present invention is characterized in that it comprises a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- the step for fatty acid metabolism in the context of the present invention is a step wherein a decomposition or synthesis is performed using a fatty acid with 4 to 30 carbon atoms as a starting material by, for example, enzymes secreted via an endocrine or exocrine pathway by proteobacteria under a predetermined dissolved oxygen concentration.
- a decomposition or synthesis is performed using a fatty acid with 4 to 30 carbon atoms as a starting material by, for example, enzymes secreted via an endocrine or exocrine pathway by proteobacteria under a predetermined dissolved oxygen concentration.
- Examples include a method for culturing the proteobacteria in a culture media including the fatty acid in the context of the present invention under a predetermined dissolved oxygen concentration.
- the dissolved oxygen concentration during metabolism in the step for fatty acid metabolism in the context of the present invention is 0.1 mg/L or more.
- the dissolved oxygen concentration is less than 0.1 mg/L, the proteobacteria activity tends to become low, resulting in a significantly low fatty acid metabolism efficiency.
- the dissolved oxygen concentration is 8 mg/L or less, more preferably 5 mg/L or less, still more preferably 3 mg/L or less.
- the dissolved oxygen concentration is over 8 mg/L, the fatty acid tends to be oxidized by oxygen in the culture media, resulting in the reduced plant activation activity.
- dissolved oxygen levels are values detected by using PO electrodes by a diaphragm galvanic electrode method or diaphragm polarographic method using a dissolved oxygen meter from HORIBA, Ltd.
- the dissolved oxygen concentration in the context of the present invention may be adjusted according to, for example, a culture vessel, shaking speed, and an aeration volume.
- the culture condition in the step for fatty acid metabolism in the context of the present invention may be a similar condition as any of conventional conditions applied for culturing the conventional aerobic bacteria, other than the dissolved oxygen concentration, which is, in the present invention, within the predetermined range.
- Exemplary conditions include for instance a culturing method wherein an aerating cultivation is employed for 3 to 7 days by shaking a culture flask, or using a spinner flask or jar fermentor.
- the culture period may be a period during which, for example, an emulsification or a decomposition of the fatty acid is sufficiently employed, however, the culture period can be altered according to the shaking condition or amount of microorganisms to be employed.
- the end point of the step for fatty acid metabolism is determined by detecting the degree of decomposition of fatty acid from, for example, the absorbance at wavelength 230 nm, thin layer chromatography (TLC), high performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), or liquid chromatography-mass spectrometry (LC-MS).
- the temperature in the step for fatty acid metabolism in the context of the present invention may be adapted according to the proteobacteria to be used, and the step is preferably performed under the condition of the temperature of 10 to 40° C., more preferably 20 to 30° C. in terms of fatty acid metabolism efficiency.
- fatty acid and proteobacteria described herein in the context of plant activator of the present invention can be adapted for the fatty acid and proteobacteria for the step for fatty acid metabolism in the context of the present invention.
- a step for pre-culturing proteobacteria is not particularly limited, and may be any conventional methods for culturing aerobic bacteria.
- the proteobacterial cells may be collected by, for example, centrifugation, and subjected to the step for fatty acid metabolism.
- the plant activator obtainable from a manufacturing method of the present invention includes a biosurfactant in addition to the fatty acid metabolite, so that the fatty acid as well as the fatty acid metabolite become water soluble.
- the biosurfactant according to the present invention is a surfactant produced by proteobacteria.
- the plant activator of the present invention may be obtained as a culture solution which is a mixture of, for example, culture media, substances secreted by proteobacteria containing a biosurfactant, and bacterial cells.
- This culture solution may be adapted for the plant activator of the present invention as it is or after a removal of bacterial cells from this culture solution by, for example, a centrifugation.
- the culture solution can be used without dilution, preferably the culture solution is used after dilution because it may cause a shrinking of a plant part to which the culture solution is applied due to the osmotic effect caused by an evaporation of solution and a concentration of mineral components at a high temperature.
- a dilution ratio is not particularly limited unless it provides a desirable effect of the present invention, and preferably it would be 100 to 500 times dilution.
- the bacterial cells once removed from the culture solution, may be cultured again in the culture media containing fatty acid, and then the step for fatty acid metabolism can be repeated.
- the number of bacterial cells in the culture broth was 5 ⁇ 10 8 cells/mL. After the culturing, the culture broth was subjected to the centrifugation at 15,000 ⁇ g, at temperature of 20° C., isolating the bacterial cells from the culture broth, and then the bacterial cells were collected.
- the decomposition of linoleic acid was determined through the analysis of the culture broth by measuring the absorbance at wavelength 230 nm using BioSpec-mini spectrophotometer (Shimadzu Scientific Instruments) and by estimating the amount of peroxylipid formation, which is one of the intermediate products from the degradation of linoleic acid. After the culturing, the culture broth containing the bacterial cells was evaluated as a plant activator for test as described below.
- the plant activator for test which was 500 times diluted with water, was sprayed to the true leaves of cucumber plant grown in the pot. 24 hours after spraying, pathogenic bacteria was inoculated to the spray treated true leaves by making a contact with a filter paper impregnated with Botrytis cinerea spore suspension. Then the cucumber plant was grown at 23 ⁇ 2° C. in a high humidity environment for 5 days, and the pathogenic bacteria inoculated part was evaluated. The results are shown in FIG. 1 (formerly Table 1). The prevention effect was determined according to the following criteria.
- ⁇ no disease symptoms
- ⁇ disease symptoms such as browning caused by, for example, necrosis was slightly recognized.
- ⁇ disease symptoms such as browning symptoms caused by, for example, necrosis or yellowing of the whole pathogenic bacteria inoculated part was clearly recognized.
- X browning caused by, for example, necrosis was observed on the whole pathogenic bacteria inoculated part, or the disease symptoms which made a hole at the pathogenic bacteria inoculated part was recognized even though the browning area was not large.
- the cucumber plants were treated similar to Example 1 except that the water, 500 times diluted pyroligneous acid, 0.04% aqueous sorbitan fatty acid solution, a mixed aqueous solution of 0.2% potassium carbonate and 0.01% polyoxyethylene nonylphenylether, or emulsified 0.08% tetrachloroisophthalonitrile aqueous solution was used instead of the plant activator for test.
- the results are shown in FIG. 1 .
- the roots of Arabidopsis thaliana grown in the soil were treated by applying the 10 times, 100 times or 500 times diluted solution of the plant activator for test using the watering. 24 hours after the treatment, bacterial soft rot causing bacteria ( Erwinia carotovora subsp. Carotovora ) was inoculated on the leaves and stems above the ground. The plants were then grown at 23 ⁇ 2° C. in a high humidity environment for 3 days, and the disease symptoms at the pathogenic bacteria inoculated part had been evaluated up to one week after. The results are shown in Table 2. The disease prevention effect was determined according to the following criteria.
- ⁇ the ratio of the area of leaves with no disease symptoms out of total area is 1.60 times or greater than the ratio observed in untreated leaves.
- ⁇ the ratio of the area of leaves with no disease symptoms out of total area is 1.40 to 1.59 times than the ratio observed in untreated leaves.
- ⁇ the ratio of the area of leaves with no disease symptoms out of total area is 1.20 to 1.39 times than the ratio observed in untreated leaves.
- X the ratio of the area of leaves with no disease symptoms out of total area is 1.20 times less than the ratio observed in untreated leaves.
- FIG. 2 shows the expression levels of PR1, PR2 and PR5 genes specific to the salicylic acid mediated signaling pathway and PR3, PR4, and PDF1 genes specific to the jasmonate mediated signaling pathway.
- FIG. 3 show a real-time PCR amplification curve for PR1.
- the roots of Arabidopsis thaliana were treated similar to Example 2 except that the water, peroxylipid, probenazole, isotianil, acibenzolar-S-methyl (ASM), 3′-chloro-4,4′-dimethyl-1,2,3-thiadiazole-5-carboxianilide (tiadinil), ketol fatty acid solution 1, or ketol fatty acid solution 2 was used instead of the plant activator for test. The results are shown in Table 2.
- the peroxylipid used in Comparative example 7 was prepared according to the preparation method described below.
- the spot which was visualized by UV light and sulfuric acid just below the spot of the starting material was a spot for peroxylipid, and the reaction was stopped when the formation of peroxylipid was visually observed to reach about 40 to 50% of the starting material.
- the resulting reaction mixture was neutralized with 5% hydrochloric acid and chloroform was added, and then the chloroform layer was recovered, washed with water and saturated brine using a separatory funnel, and then the resulting chloroform layer was dried over anhydrous sodium sulfate, filtered, and collected, and concentrated and vacuum-dried to obtain linoleic acid oxide in the form of a syrup.
- the solution to which 0.6 g of resulting linoleic acid oxide, 75 mg of dipotassium hydrogenphosphate, and 75 mg of magnesium sulfate heptahydrate were suspended was used as the peroxylipid.
- the ketol fatty acid solution 1 used in Comparative example 12 was prepared according to the preparation method described below.
- soybean lipoxidase (Sigma) was added to the linoleic acid suspension containing 1 g of linoleic acid, 0.15 g of dipotassium hydrogenphosphate, and 100 mL of distilled water, and the reaction mixture was stirred for 24 hours to form peroxylipid 1.
- ketol fatty acid solution 1 0.1 mg of allene oxide synthase (Sigma-Aldrich) was added and stirred for 24 hours to form ketol fatty acid, and the enzyme reaction was then stopped by adding diluted hydrochloric acid on ice to adjust the pH of reaction mixture to pH 3.0. The solution after whose pH was adjusted to 6.5 was used as ketol fatty acid solution 1.
- allene oxide synthase Sigma-Aldrich
- the ketol fatty acid solution 2 used in Comparative example 13 was prepared according to the preparation method described below.
- ketol fatty acid solution 2 0.1 mg of allene oxide synthase (Sigma-Aldrich) was added and stirred for 24 hours to form ketol fatty acid, and the enzyme reaction was then stopped by adding diluted hydrochloric acid on ice to adjust the pH of reaction mixture to pH 3.0. The solution after whose pH was adjusted to 6.5 was used as ketol fatty acid solution 2.
- allene oxide synthase Sigma-Aldrich
- the plant activator of the present invention induces resistance against the bacterial soft rot disease in Arabidopsis thaliana . Further, it is demonstrated that the amount of gene expression, related to the salicylic acid mediated signaling pathway as well as the jasmonate mediated signaling pathway, in the presence of the plant activator of the present invention is greater than those in the presence of ASM or probenazole.
- the leaves and stems of tomatoes (cultivar “Momotaro”) grown in the pot for 3 weeks were treated by applying 10 mL of undiluted solution of the plant activator for test using the watering.
- the soil (about 100 g) in the pot was moistened thoroughly before the watering.
- the bacterial wilt disease bacteria were inoculated on the leaves and roots of tomatoes 1 hour and 24 hours after the watering.
- the plants were then grown at 30° C. in a high humidity environment for 7 days, and the incidences of the bacterial wilt disease and phytotoxic damage were evaluated. The results are shown in Table 3.
- the cDNA was synthesized from total RNA isolated from each tomato 24 hours and 72 hours after the inoculation, and the expression level of individual genes specific to the salicylic acid mediated signaling pathway and the jasmonate mediated signaling pathway was analyzed by real-time PCR.
- the amount of the gene expression is represented by an index, which is a calculated ratio given that the amount of gene expression in untreated tomatoes is 1. The results are shown in Table 3.
- Tomato (cultivar “Reika”) seedlings were planted with space of 60 cm between plants in the farm field where an outburst of bacterial wilt disease was observed, and the solution of the plant activator for test, which was 50 times diluted with water, was applied either by spraying (20 mL/plant) or watering it to soil (200 mL plant) once every week. The incidences of the bacterial wilt disease and phytotoxic damage were evaluated once every week for 4 weeks. The results are shown in Table 4.
- the solution of the plant activator for test which was 10 times, 100 times or 500 times diluted with water, was applied to the leaves and stems of miniature roses (cultivar Rouge) grown in a pot right after the planting and one week after, two weeks after, and three weeks after by spraying (about 50 mL/plant), and then the plants were transferred to a sealed box inside which a wet paper towel was put and grown under a high humidity condition.
- One week after the naturally occurring damages due to disease were evaluated based on the disease prevention rate in comparison with that in the untreated, comparative section. The results are shown in Table 6.
- the wet filter paper was put on the petri dish and 30 of Western turf seeds were arranged at regular intervals on the wet filter paper.
- the solution of the plant activator for test which was 500 times diluted with water, was injected into the filter paper, and plants were incubated with a cover closed at 20 ⁇ 2° C. using 16 hours under plant growing light irradiation and 8 hours of darkness cycle repeatedly, and then, at day 3 and day 5 the germination rates of lateral root ware evaluated.
- the results are shown in Table 7.
- the culture soil for planting was put, and the turf seeds were placed and lightly covered with the red clay soil which had been grounded in mortar and sieved.
- the cell tray was put in the stainless container and water was poured into the container up to about 1 cm depth to provide a bottom-watering tray. Plants were incubated at 20 ⁇ 2° C. using 16 hours under plant growing light irradiation and 8 hours of darkness cycle repeatedly. Water was supplied when the water at the bottom of the container was used up completely.
- plants were spray-treated by spraying the solution of the plant activator for test, which was 10 times, 100 times or 500 times diluted with water, to each cell (5 mL per cell), and the length of the leaves and stems growth in 14 days were measured and evaluated. The results are shown in Table 8.
- the turf seeds were treated similar to Example 12 except that the water was used instead of the plant activator for test. The results are shown in Table 8.
- the ridge was watered adequately to soften the soil, and then the plants were pulled out from the soil while loosening the soil covering the roots.
- the plant was cut at 1 cm above ground level, and the root side was washed with water, dried for one day at room temperature, and then dried in thermostatic drier (SANYO Electric Co., Ltd., MOV-112U) at 60° C. for 24 hours, and the dried weight was weighed using an electronic balance (Shimadzu Scientific Instruments, UX220H). The measurement results obtained for optionally selected three plants are shown in FIGS. 3 and 4 .
- the eggplant seedlings were treated similar to Example 15 except that the no treatment was applied.
- the results are shown in Tables 9 and 10, and FIGS. 3 and 4 .
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Biodiversity & Conservation Biology (AREA)
- Forests & Forestry (AREA)
- Ecology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Toxicology (AREA)
- Cultivation Of Plants (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dispersion Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The objective of the invention is to provide a plant activator with superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination. A plant activator comprising a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1-8 mg/L, and a method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L. A method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L.
Description
- The present invention relates to a plant activator and a method of manufacturing the same.
- For the purpose of promoting the plant growth, some measures, such as an optimization of temperature conditions or daylight conditions, or a fertilization, have been implemented for a long time. However, those measures have their limitations. For example, increasing an amount of a fertilizer to be used for a fertilization neither provides a further desirable growth-promoting effect beyond a certain level, nor, applying too much fertilizer would cause a plant growth disorder and may result in a contamination of the soil.
- Therefore, in addition to those measures, there has been some reports including a growth promotion using a plant activator having, for example, a plant growth control activity such as growth promotion (which refers to the concept that includes an enlargement of leaves and stems and a growth promotion of tubers and tuberous roots), sleep suppression, imparting a stress resistance to plant, and anti-aging.
Reference 1 describes a plant activator comprising a ketol fatty acid with 4 to 24 carbon atoms as an active ingredient. - Meanwhile, the plant disease and insect pest control depends largely on synthesized agrochemicals, however, in view of the soil contamination as well as human health damage, reducing the amount of the agrochemical to be used has been required.
- Some measures using a disease resistance inducing agent are known as a method for controlling a plant disease or pests to protect plants without using agrochemicals. Examples of resistance inducing agents include, for example, probenazole, isotianil, acibenzolar-S-methyl (ASM), 3′-chloro-4,4′-dimethyl-1,2,3-thiadiazole-5-carboxianilide (tiadinil), and Validamycin.
-
- Patent Document 1: JP 2001-131006 A
- Patent Document 2: JP H6-305921 A
- The effect of the plant activator disclosed in
Patent Document 1 is still not enough, and the plant activator having a better activation effect is in need. Also, the conventional resistance-inducing agents are chemically synthesized, so that their toxicities are extremely high. Aforementioned agents including probenazole, isotianil, acibenzolar-S-methyl (ASM), 3′-chloro-4,4′-dimethyl-1,2,3-thiadiazole-5-carboxianilide (tiadinil) may induce the systemic acquired resistance that is activated through the salicylic acid and induced by the exposure to elicitors such as pathogenic bacteria and viruses (salicylic acid mediated signaling pathway), but does not induce the resistance to be activated thorough the jasmonic acid (and ethylene) that is synthesized in response to insect herbivory or insect injury (jasmonate mediated signaling pathway). Validamycin has been reported to be effective against wilt disease in solanaceous plants, however, the use of Validamycin in tomatoes has, as an exception, the problem that it could cause phytotoxic damage, and thus it should not be used for tomatoes.Patent Document 2 discloses the use of chemically synthesized linoleic acid peroxide as a plant growth regulator, however, it did not exhibit enough efficacy in preventing disease damage. - It has been known that the fatty acid oxide including a peroxylipid exhibits antibacterial activity. It has also been known that a jasmonic acid, for example, is biosynthezised in plants from fatty acid such as linolenic acid. However, it is not known that metabolites from fatty acid oxidation by microbial metabolization process have resistance-inducing activity.
- Further those resistance-inducing agents and peroxylipids are only very slightly water soluble, and thus, one would normally have to use strong emulsifiers or dispersants when using them for treatment.
- In view of such problems described above, it is the intention of the present invention to provide a plant activator having superior resistance-inducing activity and growth-promoting activity and low toxicity and soil contamination and to provide a manufacturing method thereof.
- The present invention relates to a plant activator comprising a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- It may be preferable for the plant activator that the fatty acid is a liquid fatty acid at a temperature of 20° C.
- It may be preferable for the plant activator that the proteobacteria is a proteobacteria that has been pre-cultured to 1×108 to 9×1010 cells/mL.
- It may be preferable for the plant activator that the metabolism is a metabolism in the presence of at least one type of mineral selected from Mg, P, Na and K.
- It may be preferable that the plant activator comprises a biosurfactant.
- It may be preferable for the plant activator that the metabolism is a metabolism under a condition of temperature from 10 to 40° C.
- It may be preferable that the plant activator serves as a resistance-inducing agent.
- It may be preferable that the plant activator serves as a prophylactic agent for a wilt disease in solanaceous plants.
- Further the present invention relates to a method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- It may be preferable for the method for manufacturing a plant activator that the fatty acid is liquid at a temperature of 20° C.
- It may be preferable for the method for manufacturing a plant activator that the proteobacteria has been pre-cultured to 1×108 to 9×1010 cells/mL.
- It may be preferable that the method for manufacturing a plant activator comprises the step for fatty acid metabolism performed in the presence of at least one type of mineral selected from Mg, P, Na and K.
- It may be preferable for the method for manufacturing a plant activator that the plant activator comprises a biosurfactant.
- It may be preferable that the method for manufacturing a plant activator comprises the step for fatty acid metabolism performed under a condition of temperature from 10 to 40° C.
- It may be preferable for the method for manufacturing a plant activator that the plant activator serves as a resistance-inducing agent.
- It may be preferable for the method for manufacturing a plant activator that the plant activator serves as a prophylactic agent for a wilt disease in solanaceous plants.
- The plant activator of the present invention has superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination. Further, according to the method for manufacturing a plant activator of the present invention, the plant activator having superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination can be produced.
-
FIG. 1 is a table (formerly “Table 1” in the international phase) that shows test results of the plant activator in an example 1 followed by five comparative examples 1 through 5. -
FIG. 2 is a graph showing a gene expression level in Arabidopsis thaliana. -
FIG. 3 shows a real-time PCR amplification curve of PR1 gene. -
FIG. 4 is a picture showing a result of a growth-promoting activity in eggplant root. -
FIG. 5 is a picture showing a result of a growth-promoting activity in eggplant root. - A plant activator of the present invention is characterized in that it comprises a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- A fatty acid metabolite of the present invention can render plants resistance and promote plant growth by being sprayed or applied to a plant root, stem or leaf. This may be because the fatty acid metabolite includes a substance or a precursor of the substance that activates the salicylic acid mediated signaling pathway or jasmonate mediated signaling pathway associated with resistance induction. Further, the fatty acid metabolite may also include a substance that activates plant growth, given that plant growth-promoting effect can be seen.
- A metabolism in the context of the present invention involves performing a decomposition or synthesis using a fatty acid with 4 to 30 carbon atoms as a starting material by, for example, enzymes secreted via an endocrine or exocrine pathway by proteobacteria under a predetermined dissolved oxygen concentration. Examples include a method for culturing the proteobacteria in a culture media including the fatty acid in the context of the present invention under a predetermined dissolved oxygen concentration.
- The number of carbon atoms in the fatty acid to be used in the present invention is from 4 to 30, preferably 10 to 20. When the number of carbon atoms is less than 4, the melting point and/or boiling point of the fatty acid is low, so that it tends to become highly volatile at a culture temperature and can hardly remain in the culture media. When the number of carbon atoms is more than 30, the melting point and/or boiling point of the fatty acid is high, so that it tends to become a solid at a culture temperature and cannot be mixed with a culture media, resulting in the separation of the fatty acid from the culture media. However, it should be noted that the melting point of the fatty acid does not always depend on only the number of carbon atoms based on the number of hydrogen bonds.
- The fatty acid to be used in the present invention is preferably a liquid fatty acid at a temperature from 20 to 30° C. in terms of their metabolism efficiency as well as to prevent solidification in the culture media.
- The fatty acid in the context of the present invention may be either a saturated fatty acid or a unsaturated fatty acid, or a mixture including both fatty acids. Further a vegetable oil, a triglyceride form, or a free fatty acid may be used. Preferably, the fatty acid is a free fatty acid (monocarboxylic acid) in terms of its superior decomposition rate.
- Exemplary examples of free fatty acid with 4 to 30 carbon atoms include for instance, butanoic acid (butyric acid), pentanoic acid (valeric acid), caproic acid, enanthic acid (heptylic acid), caprylic acid, pelargonic acid, capric acid, lauric acid, myristic acid, pentadecylic acid, palmitic acid, palmitoleic acid, margaric acid, stearic acid, oleic acid, vaccenic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, eleostearic acid, arachidic acid, mead acid, arachidonic acid, behenic acid, lignoceric acid, nervonic acid, cerotic acid, montanic acid, and melissic acid. Preferably, the fatty acid is a fatty acid which has 10 to 20 carbon atoms such as capric acid, lauric acid, myristic acid, pentadecylic acid, palmitic acid, palmitoleic acid, margaric acid, stearic acid, oleic acid, vaccenic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, eleostearic acid, arachidic acid, mead acid, or arachidonic acid. More preferably, the fatty acid is a fatty acid which has 18 carbon atoms such as oleic acid, linoleic acid, α-linolenic acid, or γ-linolenic acid.
- Preferably, a fatty acid content in the culture media is 100 g/L or less, more preferably 60 g/L or less, still more preferably 12 g/L or less when the culture media containing the fatty acid is used. When the fatty acid content is over 100 g/L, emulsification of the fatty acid with water in the culture media may become difficult, deteriorating metabolism efficiency or resulting in an inhibition of proteobacteria growth. Further, although the lower limit of the fatty acid content is not particularly limited, the fatty acid content is preferably 1.0 g/L or more.
- Preferably, the culture media containing a fatty acid in the context of the present invention also contains a mineral component. Exemplary examples of mineral components include for instance, but not particularly limited to, a mineral component which is used for culturing microorganism. Examples include for instance a component containing magnesium (Mg), phosphorous (P), sodium (Na), or potassium (K). These components can be used alone or in combination. A mineral component content in the culture media is not particularly limited, and can be adapted to the content used with a conventional method for culturing an aerobic bacteria.
- A proteobacteria which can be used in the context of the present invention is not particularly limited unless it provides a desirable effect of the present invention. Preferably, the proteobacteria is a proteobacteria which has a suitable growth temperature (an optimum temperature) of from 10 to 40° C., more preferably 20 to 30° C. in terms of its fatty acid metabolism efficiency as well as growth efficiency.
- Preferably, a proteobacteria in the context of the present invention is a pre-cultured proteobacteria, preferably, to the cell concentration at the end of pre-culture of 1×108 to 9×1010 cells/mL, in such case the proteobacteria can have superior fatty acid metabolism efficiency.
- With the context of the present invention a dissolved oxygen concentration during metabolism is 0.1 mg/L or more. When the dissolved oxygen concentration is less than 0.1 mg/L, the proteobacteria activity tends to become low, resulting in a significantly low fatty acid metabolism efficiency. Preferably, the dissolved oxygen concentration is 8 mg/L or less, more preferably 5 mg/L or less, still more preferably 3 mg/L or less. When the dissolved oxygen concentration is over 8 mg/L, the fatty acid tends to be oxidized by oxygen in the culture media, resulting in the reduced plant activation activity. In this context, dissolved oxygen levels are values detected by using PO electrodes by a diaphragm galvanic electrode method or diaphragm polarographic method using a dissolved oxygen meter from HORIBA, Ltd.
- The temperature during metabolism can be adapted suitably according to the proteobacteria to be used, and is preferably from 10 to 40° C., more preferably from 20 to 30° C. in terms of fatty acid metabolism efficiency.
- Preferably, in terms of the fatty acid metabolism efficiency and the handleability, the plant activator of the present invention includes a biosurfactant in addition to the fatty acid metabolite, so that the fatty acid as well as the fatty acid metabolite becomes water soluble. In this context, the biosurfactant according to the present invention is a surfactant produced by proteobacteria.
- The plant activator of the present invention is significantly effective as a resistance-inducing agent and growth promoting agent with a low toxicity and soil contamination. The plant activator of the present invention is particularly effective as a resistance-inducing agent compared to the conventional resistance-inducing agents in that the plant activator of the present invention can activate both of respective resistance inductions through a salicylic acid mediated signaling pathway and through a jasmonate mediated signaling pathway. Further, the plant activator of the present invention can activate a resistance induction and plant growth in all parts of the plant by being applied to a part of the plant root, stem or leaf.
- While, as described above, Validamycin, which is known as a resistance-inducing agent against wilt disease in solanaceous plants, should not be used in tomatoes, as an exception, because it could cause phytotoxic damage, the plant activator of the present invention can exhibit a resistance-inducing effect even on the wilt disease in tomatoes without causing any phytotoxic damages.
- The plant activator of the present invention can be widely applied to the plants, regardless of their species. Examples of the plants include dicotyledonous plants of Cucurbitaceae family or Solanaceae family, and monocotyledonous plants of Gramineae family. Further, Methods for application includes, for example, a method of applying or spraying to, for example, a plant root, stem or leaf, and a method of spraying on the soil or watering.
- A method for manufacturing a plant activator containing a fatty acid metabolite of the present invention is characterized in that it comprises a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1 to 8 mg/L.
- The step for fatty acid metabolism in the context of the present invention is a step wherein a decomposition or synthesis is performed using a fatty acid with 4 to 30 carbon atoms as a starting material by, for example, enzymes secreted via an endocrine or exocrine pathway by proteobacteria under a predetermined dissolved oxygen concentration. Examples include a method for culturing the proteobacteria in a culture media including the fatty acid in the context of the present invention under a predetermined dissolved oxygen concentration.
- The dissolved oxygen concentration during metabolism in the step for fatty acid metabolism in the context of the present invention is 0.1 mg/L or more. When the dissolved oxygen concentration is less than 0.1 mg/L, the proteobacteria activity tends to become low, resulting in a significantly low fatty acid metabolism efficiency. Preferably, the dissolved oxygen concentration is 8 mg/L or less, more preferably 5 mg/L or less, still more preferably 3 mg/L or less. When the dissolved oxygen concentration is over 8 mg/L, the fatty acid tends to be oxidized by oxygen in the culture media, resulting in the reduced plant activation activity. In this context, dissolved oxygen levels are values detected by using PO electrodes by a diaphragm galvanic electrode method or diaphragm polarographic method using a dissolved oxygen meter from HORIBA, Ltd.
- The dissolved oxygen concentration in the context of the present invention may be adjusted according to, for example, a culture vessel, shaking speed, and an aeration volume.
- The culture condition in the step for fatty acid metabolism in the context of the present invention may be a similar condition as any of conventional conditions applied for culturing the conventional aerobic bacteria, other than the dissolved oxygen concentration, which is, in the present invention, within the predetermined range. Exemplary conditions include for instance a culturing method wherein an aerating cultivation is employed for 3 to 7 days by shaking a culture flask, or using a spinner flask or jar fermentor.
- Preferably, the culture period may be a period during which, for example, an emulsification or a decomposition of the fatty acid is sufficiently employed, however, the culture period can be altered according to the shaking condition or amount of microorganisms to be employed. In this context, preferably the end point of the step for fatty acid metabolism is determined by detecting the degree of decomposition of fatty acid from, for example, the absorbance at wavelength 230 nm, thin layer chromatography (TLC), high performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), or liquid chromatography-mass spectrometry (LC-MS).
- The temperature in the step for fatty acid metabolism in the context of the present invention may be adapted according to the proteobacteria to be used, and the step is preferably performed under the condition of the temperature of 10 to 40° C., more preferably 20 to 30° C. in terms of fatty acid metabolism efficiency.
- The fatty acid and proteobacteria described herein in the context of plant activator of the present invention can be adapted for the fatty acid and proteobacteria for the step for fatty acid metabolism in the context of the present invention.
- In this context, a step for pre-culturing proteobacteria is not particularly limited, and may be any conventional methods for culturing aerobic bacteria. Preferably, after the preculture, only the proteobacterial cells may be collected by, for example, centrifugation, and subjected to the step for fatty acid metabolism.
- Preferably, in terms of the fatty acid metabolism efficiency and the handleability, the plant activator obtainable from a manufacturing method of the present invention includes a biosurfactant in addition to the fatty acid metabolite, so that the fatty acid as well as the fatty acid metabolite become water soluble. In this context, the biosurfactant according to the present invention is a surfactant produced by proteobacteria.
- The plant activator of the present invention may be obtained as a culture solution which is a mixture of, for example, culture media, substances secreted by proteobacteria containing a biosurfactant, and bacterial cells. This culture solution may be adapted for the plant activator of the present invention as it is or after a removal of bacterial cells from this culture solution by, for example, a centrifugation. Although the culture solution can be used without dilution, preferably the culture solution is used after dilution because it may cause a shrinking of a plant part to which the culture solution is applied due to the osmotic effect caused by an evaporation of solution and a concentration of mineral components at a high temperature. A dilution ratio is not particularly limited unless it provides a desirable effect of the present invention, and preferably it would be 100 to 500 times dilution. In this context, the bacterial cells, once removed from the culture solution, may be cultured again in the culture media containing fatty acid, and then the step for fatty acid metabolism can be repeated.
- The present invention will be illustrated in detail by way of the Examples below, although the present invention shall be not limited to those specific Examples.
- To 1 L of water in the glass Erlenmeyer flask 20 g of peptone (Difco, enzymatic digest of protein), 1.5 g of magnesium sulfate heptahydrate, and 1.5 g of dipotassium hydrogenphosphate were dissolved, autoclaved at 121° C. for 20 min to render it sterile, and after cooled to room temperature, the suspension containing proteobacterial cells was inoculated. The mouth of the Erlenmeyer flask was sealed with a silicone closure. After inoculation, cells in the flask were cultured at 20° C. for 24 hours with shaking (120 rpm) using Bioshaker (Taitec, BR-23UM). The number of bacterial cells in the culture broth was 5×108 cells/mL. After the culturing, the culture broth was subjected to the centrifugation at 15,000×g, at temperature of 20° C., isolating the bacterial cells from the culture broth, and then the bacterial cells were collected.
- To 1 L of sterilized water in the glass Erlenmeyer flask 12 g of linoleic acid (Wako, first grade), 1.5 g of magnesium sulfate heptahydrate, 1.5 g of dipotassium hydrogenphosphate, and the whole amount of the bacterial cells obtained from the pre-culturing step were added. The bacterial cells in the flask were cultured at 20° C. for 4 days with shaking (120 rpm) using Bioshaker (Taitec, BR-23UM) under the condition of a dissolved oxygen concentration of 4 mg/L. The decomposition of linoleic acid was determined through the analysis of the culture broth by measuring the absorbance at wavelength 230 nm using BioSpec-mini spectrophotometer (Shimadzu Scientific Instruments) and by estimating the amount of peroxylipid formation, which is one of the intermediate products from the degradation of linoleic acid. After the culturing, the culture broth containing the bacterial cells was evaluated as a plant activator for test as described below.
- The plant activator for test, which was 500 times diluted with water, was sprayed to the true leaves of cucumber plant grown in the pot. 24 hours after spraying, pathogenic bacteria was inoculated to the spray treated true leaves by making a contact with a filter paper impregnated with Botrytis cinerea spore suspension. Then the cucumber plant was grown at 23±2° C. in a high humidity environment for 5 days, and the pathogenic bacteria inoculated part was evaluated. The results are shown in
FIG. 1 (formerly Table 1). The prevention effect was determined according to the following criteria. - ⊚: no disease symptoms
∘: disease symptoms such as browning caused by, for example, necrosis was slightly recognized.
Δ: disease symptoms such as browning symptoms caused by, for example, necrosis or yellowing of the whole pathogenic bacteria inoculated part was clearly recognized.
X: browning caused by, for example, necrosis was observed on the whole pathogenic bacteria inoculated part, or the disease symptoms which made a hole at the pathogenic bacteria inoculated part was recognized even though the browning area was not large. - The cucumber plants were treated similar to Example 1 except that the water, 500 times diluted pyroligneous acid, 0.04% aqueous sorbitan fatty acid solution, a mixed aqueous solution of 0.2% potassium carbonate and 0.01% polyoxyethylene nonylphenylether, or emulsified 0.08% tetrachloroisophthalonitrile aqueous solution was used instead of the plant activator for test. The results are shown in
FIG. 1 . - It should be appreciated from the results shown in
FIG. 1 (formerly Table 1) that the plant activator of the present invention induces resistance against the gray mold disease in cucumber plants. - The roots of Arabidopsis thaliana grown in the soil were treated by applying the 10 times, 100 times or 500 times diluted solution of the plant activator for test using the watering. 24 hours after the treatment, bacterial soft rot causing bacteria (Erwinia carotovora subsp. Carotovora) was inoculated on the leaves and stems above the ground. The plants were then grown at 23±2° C. in a high humidity environment for 3 days, and the disease symptoms at the pathogenic bacteria inoculated part had been evaluated up to one week after. The results are shown in Table 2. The disease prevention effect was determined according to the following criteria.
- ⊚: the ratio of the area of leaves with no disease symptoms out of total area is 1.60 times or greater than the ratio observed in untreated leaves.
∘: the ratio of the area of leaves with no disease symptoms out of total area is 1.40 to 1.59 times than the ratio observed in untreated leaves.
Δ: the ratio of the area of leaves with no disease symptoms out of total area is 1.20 to 1.39 times than the ratio observed in untreated leaves.
X: the ratio of the area of leaves with no disease symptoms out of total area is 1.20 times less than the ratio observed in untreated leaves. - Further, the cDNA was synthesized from total RNA isolated from each
Arabidopsis thaliana plant 24 hours after treatment, and the expression level of individual genes specific to the salicylic acid mediated signaling pathway and the jasmonate mediated signaling pathway was analyzed by real-time PCR. The gene expression levels were respectively normalized using the house keeping gene as negative control.FIG. 2 shows the expression levels of PR1, PR2 and PR5 genes specific to the salicylic acid mediated signaling pathway and PR3, PR4, and PDF1 genes specific to the jasmonate mediated signaling pathway.FIG. 3 show a real-time PCR amplification curve for PR1. - The roots of Arabidopsis thaliana were treated similar to Example 2 except that the water, peroxylipid, probenazole, isotianil, acibenzolar-S-methyl (ASM), 3′-chloro-4,4′-dimethyl-1,2,3-thiadiazole-5-carboxianilide (tiadinil), ketol
fatty acid solution 1, or ketolfatty acid solution 2 was used instead of the plant activator for test. The results are shown in Table 2. - The peroxylipid used in Comparative example 7 was prepared according to the preparation method described below.
- To Erlenmeyer flask 100 mL of distilled water and 1 mL of 32% sodium hydroxide solution were added and stirred with magnetic stirrer, and then heated to 50° C. in water bath. Then 1.2 g of linoleic acid (Wako, first grade), and 0.53 mL of hydrogen peroxide (35%) were added and the reaction mixture was refluxed at 50° C. in water bath at atmospheric pressure for 3 days. The reaction was monitored using a silica gel coated plate (Merck, 60F254 on glass plate), the solvent mixture (chloroform:methanol=10:1) as a developing solvent, and sulfuric acid as coupler. The spots on the glass plate were visualized by a dark spot formed by sulfuric acid. The spot which was visualized by UV light and sulfuric acid just below the spot of the starting material was a spot for peroxylipid, and the reaction was stopped when the formation of peroxylipid was visually observed to reach about 40 to 50% of the starting material. The resulting reaction mixture was neutralized with 5% hydrochloric acid and chloroform was added, and then the chloroform layer was recovered, washed with water and saturated brine using a separatory funnel, and then the resulting chloroform layer was dried over anhydrous sodium sulfate, filtered, and collected, and concentrated and vacuum-dried to obtain linoleic acid oxide in the form of a syrup. The solution to which 0.6 g of resulting linoleic acid oxide, 75 mg of dipotassium hydrogenphosphate, and 75 mg of magnesium sulfate heptahydrate were suspended was used as the peroxylipid.
- The ketol
fatty acid solution 1 used in Comparative example 12 was prepared according to the preparation method described below. - 10 mg of soybean lipoxidase (Sigma) was added to the linoleic acid suspension containing 1 g of linoleic acid, 0.15 g of dipotassium hydrogenphosphate, and 100 mL of distilled water, and the reaction mixture was stirred for 24 hours to form
peroxylipid 1. The formation of peroxylipid was identified by TLC comparison with a standard compound (developing solvent of chloroform:methanol=20:1, visualized by sulfuric acid) and by the increase in absorbance at 234 nm. It was also identified by NMR that the main composition in theperoxylipid 1 was 13HPODE ((9Z, 11E)-13-hydroperoxy-9, 11-octadecadienoic acid). - To the resulting
peroxylipid 1, 0.1 mg of allene oxide synthase (Sigma-Aldrich) was added and stirred for 24 hours to form ketol fatty acid, and the enzyme reaction was then stopped by adding diluted hydrochloric acid on ice to adjust the pH of reaction mixture to pH 3.0. The solution after whose pH was adjusted to 6.5 was used as ketolfatty acid solution 1. - The ketol
fatty acid solution 2 used in Comparative example 13 was prepared according to the preparation method described below. - 10 g of maize embryos was grounded in a mortar, and then 30 mL of distilled water was added and the mixture was further grounded in a mortar to make a suspension. The resulting suspension was centrifuged at 16000 rpm for 15 min to obtain a supernatant, and the resulting supernatant was used as a substance containing lipoxygenase from maize embryos. 10 mg of the substance containing lipoxygenase from maize embryos was added to the linoleic acid suspension containing 1 g of linoleic acid, 0.15 g of dipotassium hydrogenphosphate, and 100 mL of distilled water, and the reaction mixture was stirred for 24 hours to form
peroxylipid 2. The formation of peroxylipid was identified by TLC comparison with a standard compound (developing solvent of chloroform:methanol=20:1, visualized by sulfuric acid) and by the increase in absorbance at 234 nm. It was also identified by NMR that the main composition in theperoxylipid 2 was 9HPODE ((9S, 10E, 12Z)-9-hydroperoxy-10, 12-octadecadienoic acid). - To the resulting
peroxylipid 2, 0.1 mg of allene oxide synthase (Sigma-Aldrich) was added and stirred for 24 hours to form ketol fatty acid, and the enzyme reaction was then stopped by adding diluted hydrochloric acid on ice to adjust the pH of reaction mixture to pH 3.0. The solution after whose pH was adjusted to 6.5 was used as ketolfatty acid solution 2. -
TABLE 2 disease agent for treatment prevention Example 2 10 times diluted ⊚ solution of plant activator for test 3 100 times diluted ⊚ solution of plant activator for test 4 500 times diluted ◯ solution of plant activator for test Comparative 6 water X example 7 peroxylipid Δ 8 probenazole Δ 9 isotianil Δ 10 ASM ⊚ 11 tiadinil X 12 ketol fatty acid X solution 1 13 ketol fatty acid X solution 2 - From the results shown in Table 2 and
FIG. 2 , it should be appreciated that the plant activator of the present invention induces resistance against the bacterial soft rot disease in Arabidopsis thaliana. Further, it is demonstrated that the amount of gene expression, related to the salicylic acid mediated signaling pathway as well as the jasmonate mediated signaling pathway, in the presence of the plant activator of the present invention is greater than those in the presence of ASM or probenazole. - The leaves and stems of tomatoes (cultivar “Momotaro”) grown in the pot for 3 weeks were treated by applying 10 mL of undiluted solution of the plant activator for test using the watering. The soil (about 100 g) in the pot was moistened thoroughly before the watering. The bacterial wilt disease bacteria were inoculated on the leaves and roots of
tomatoes 1 hour and 24 hours after the watering. The plants were then grown at 30° C. in a high humidity environment for 7 days, and the incidences of the bacterial wilt disease and phytotoxic damage were evaluated. The results are shown in Table 3. - Further, the cDNA was synthesized from total RNA isolated from each
tomato 24 hours and 72 hours after the inoculation, and the expression level of individual genes specific to the salicylic acid mediated signaling pathway and the jasmonate mediated signaling pathway was analyzed by real-time PCR. In this example, the amount of the gene expression is represented by an index, which is a calculated ratio given that the amount of gene expression in untreated tomatoes is 1. The results are shown in Table 3. - The leaves and stems of tomatoes were treated similar to Example 5 except that the water and the fatty acid (linoleic acid) were used instead of the plant activator for test. The results are shown in Table 3.
-
TABLE 3 amount of gene expression salicylic acid jasmonate incidences mediated mediated agent for incidences of phytotoxic signaling pathway signaling pathway treatment of disease damage 24 hours 72 hours 24 hours 72 hours Example 5 plant activator 50% 0% 11.0 7 3 3.5 for test Comparative 14 untreated 100% 0% 1 1 1 1 example 15 fatty acid 100% 0% 0 0 0.5 1 - It should be appreciated from the results shown in Table 3 that the plant activator of the present invention induces resistance against the bacterial wilt disease in tomatoes without causing any phytotoxic damages. Further, it is demonstrated that the amount of gene expression related to the salicylic acid mediated signaling pathway as well as the jasmonate mediated signaling pathway is high.
- Tomato (cultivar “Reika”) seedlings were planted with space of 60 cm between plants in the farm field where an outburst of bacterial wilt disease was observed, and the solution of the plant activator for test, which was 50 times diluted with water, was applied either by spraying (20 mL/plant) or watering it to soil (200 mL plant) once every week. The incidences of the bacterial wilt disease and phytotoxic damage were evaluated once every week for 4 weeks. The results are shown in Table 4.
- The leaves and stems of tomatoes were treated similar to Example 6 except that the Validamycin or no agent was used instead of the plant activator for test. The results are shown in Table 4.
-
TABLE 4 incidences of disease incidences of phytotoxic damage agent for Week Week Week Week Week Week Week Week treatment 1 2 3 4 1 2 3 4 Example 6 plant activator 0% 0% 0% 33% 0% 0% 0% 0% for test Comparative 16 untreated 0% 0% 42% 75% 0% 0% 0% 0% example 17 Validamycin 0% 0% 0% 67% 100% 100% 100% 100% - It should be appreciated from the results shown in Table 4 that the plant activator of the present invention induces resistance against the bacterial wilt disease in tomatoes without causing any phytotoxic damages.
- The solution of the plant activator for test, which was 100 times diluted with water, was applied to the leaves and stems of miniature roses (cultivar Rouge) planted in an outdoor planter right after the planting and once every week by spraying (about 50 mL/plant), and the naturally occurring damages due to disease (powdery mildew and black point disease) were evaluated on first week and fourth week. The results are shown in Table 5.
- The leaves and stems of miniature roses were treated similar to Example 7 except that 0.02% mepanipyrim or no agent was used instead of the plant activator for test. The results are shown in Table 5.
-
TABLE 5 incidences of disease black point agent for powdery mildew disease treatment Week 1 Week 4Week 1Week 4Example 7 plant activator 12.5% 20.8% 0% 0% for test Comparative 18 untreated 29.1% 25.0% 0% 0% example 19 mepanipyrim 20.0% 30.0% 0% 15% - It should be appreciated from the results shown in Table 5 that the plant activator of the present invention induces resistance against the powdery mildew and black point disease in miniature roses.
- The solution of the plant activator for test, which was 10 times, 100 times or 500 times diluted with water, was applied to the leaves and stems of miniature roses (cultivar Rouge) grown in a pot right after the planting and one week after, two weeks after, and three weeks after by spraying (about 50 mL/plant), and then the plants were transferred to a sealed box inside which a wet paper towel was put and grown under a high humidity condition. One week after the naturally occurring damages due to disease (gray mold disease) were evaluated based on the disease prevention rate in comparison with that in the untreated, comparative section. The results are shown in Table 6.
-
TABLE 6 disease prevention agent for treatment rate Example 8 10 times diluted 100% solution of plant activator for test 9 100 times diluted 89% solution of plant activator for test 10 500 times diluted 100% solution of plant activator for test - It should be appreciated from the results shown in Table 6 that the plant activator of the present invention induces resistance against the gray mold disease in miniature roses.
- The wet filter paper was put on the petri dish and 30 of Western turf seeds were arranged at regular intervals on the wet filter paper. The solution of the plant activator for test, which was 500 times diluted with water, was injected into the filter paper, and plants were incubated with a cover closed at 20±2° C. using 16 hours under plant growing light irradiation and 8 hours of darkness cycle repeatedly, and then, at
day 3 and day 5 the germination rates of lateral root ware evaluated. The results are shown in Table 7. - The Western turf seeds were treated similar to Example 11 except that the water was used instead of the plant activator for test. The results are shown in Table 7.
-
TABLE 7 germination rate agent for treatment Day 3 Day 5 Example 11 plant activator for 53% 80% test Comparative 20 water 27% 47% example - It should be appreciated from the results shown in Table 7 that the plant activator of the present invention promotes the germination of Western turf.
- To the 72 seed cell tray the culture soil for planting was put, and the turf seeds were placed and lightly covered with the red clay soil which had been grounded in mortar and sieved. The cell tray was put in the stainless container and water was poured into the container up to about 1 cm depth to provide a bottom-watering tray. Plants were incubated at 20±2° C. using 16 hours under plant growing light irradiation and 8 hours of darkness cycle repeatedly. Water was supplied when the water at the bottom of the container was used up completely. After the germination was observed in each seed cell, plants were spray-treated by spraying the solution of the plant activator for test, which was 10 times, 100 times or 500 times diluted with water, to each cell (5 mL per cell), and the length of the leaves and stems growth in 14 days were measured and evaluated. The results are shown in Table 8.
- The turf seeds were treated similar to Example 12 except that the water was used instead of the plant activator for test. The results are shown in Table 8.
-
TABLE 8 agent for length of leaves (cm) treatment Day 7 Day 10Day 12Day 14 Example 12 10 times diluted 3.0 5.1 5.7 6.2 solution of plant activator for test 13 100 times diluted 3.8 4.8 5.2 5.7 solution of plant activator for test 14 500 times diluted 2.8 4.1 4.6 5.5 solution of plant activator for test Comparative 21 water 2.5 3.5 3.9 5.1 example - It should be appreciated from the results shown in Table 8 that the plant activator of the present invention promotes the leaves and stems growth of Western turf.
- 17 Eggplant seedlings (root stock: Solanum integrifolium; scion: Solanum melongena L. cultivar “Senryo”), which had been grown up to or over 15 cm in pot, were planted with space of 60 cm between plants, and a chemical fertilizer, a mixed fertilizer, and an organic fertilizer were applied accordingly as a basal fertilizer, in addition to an additional fertilizer. The solution of the plant activator for test, which was 50 to 100 times diluted with water, was applied to the plants right after the planting and once every week by spraying (about 20 to 50 mL/plant) and by watering (about 100 to 300 mL/plant). Then, once every week the fruits which were grown to 15 cm or more were harvested and the number of the harvested fruits was evaluated. All eggplant plants were pruned to three main branches, and the main stem length had been measured and evaluated from one week after the planting. The results are shown in Table 9.
- Further, after 2 to 3 months after the planting, the ridge was watered adequately to soften the soil, and then the plants were pulled out from the soil while loosening the soil covering the roots. After pulling the plant, the plant was cut at 1 cm above ground level, and the root side was washed with water, dried for one day at room temperature, and then dried in thermostatic drier (SANYO Electric Co., Ltd., MOV-112U) at 60° C. for 24 hours, and the dried weight was weighed using an electronic balance (Shimadzu Scientific Instruments, UX220H). The measurement results obtained for optionally selected three plants are shown in
FIGS. 3 and 4 . - The eggplant seedlings were treated similar to Example 15 except that the no treatment was applied. The results are shown in Tables 9 and 10, and
FIGS. 3 and 4 . -
TABLE 9 average length of number of the harvested main stem (cm) fruits per plant agent for Week Week Week Week Week Week Week Week Week Week treatment 1 2 3 4 5 1 2 3 4 5 Example 15 plant activator 35.8 47.2 54.3 65.2 76.2 0.9 0.2 0.6 0.8 2.0 for test Comparative 22 untreated 35.6 45.5 51.7 58.4 70.4 0.9 0.1 0.5 0.5 0.9 example -
TABLE 10 agent for standard treatment dried weight (g) average deviation Example 15 plant activator 11.606 10.476 8.163 10.08 1.755 for test Comparative 22 untreated 6.313 5.721 6.561 6.20 0.4316 example - It should be appreciated from the results shown in Tables 9 and 10, and
FIGS. 3 and 4 that the plant activator of the present invention promotes the eggplant growth. - The above described results show that the plant activator of the present invention and the plant activator obtainable by the manufacturing method of the present invention have superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination.
Claims (16)
1. A plant activator comprising a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1 to 8 mg/L.
2. The plant activator of claim 1 , wherein the fatty acid is a liquid fatty acid at a temperature of 20° C.
3. The plant activator of claim 1 , wherein the proteobacteria is a proteobacteria pre-cultured to 1×108 to 9×1010 cells/mL.
4. The plant activator of claim 1 , wherein the metabolism is a metabolism in the presence of at least one type of mineral selected from Mg, P, Na and K.
5. The plant activator of claim 1 , wherein the plant activator comprises a biosurfactant.
6. The plant activator of claim 1 , wherein the metabolism is a metabolism under a condition of temperature from 10 to 40° C.
7. The plant activator of claim 1 , wherein the plant activator serves as a resistance-inducing agent.
8. The plant activator of claim 1 , wherein the plant activator serves as a prophylactic agent for a wilt disease in solanaceous plants.
9. A method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1 to 8 mg/L.
10. The method for manufacturing a plant activator of claim 9 , wherein the fatty acid is liquid at a temperature of 20° C.
11. The method for manufacturing a plant activator of claim 9 , wherein the proteobacteria is a proteobacteria pre-cultured to 1×108 to 9×1010 cells/mL.
12. The method for manufacturing a plant activator of claim 9 , wherein the step for fatty acid metabolism is performed in the presence of at least one type of mineral selected from Mg, P, Na and K.
13. The method for manufacturing a plant activator of claim 9 , wherein the plant activator comprises a biosurfactant.
14. The method for manufacturing a plant activator of claim 9 , wherein the step for fatty acid metabolism is performed under a condition of temperature from 10 to 40° C.
15. The method for manufacturing a plant activator of claim 9 , wherein the plant activator serves as a resistance-inducing agent.
16. The method for manufacturing a plant activator of claim 9 , wherein the plant activator serves as a prophylactic agent for a wilt disease in solanaceous plants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/832,837 US20220295713A1 (en) | 2016-09-08 | 2022-06-06 | Plant activator and a method of manufacturing the same |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016175861 | 2016-09-08 | ||
JP2016-175861 | 2016-09-08 | ||
PCT/JP2017/032354 WO2018047918A1 (en) | 2016-09-08 | 2017-09-07 | Plant activator and process for producing plant activator |
US201916331300A | 2019-03-07 | 2019-03-07 | |
US17/832,837 US20220295713A1 (en) | 2016-09-08 | 2022-06-06 | Plant activator and a method of manufacturing the same |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/331,300 Division US11382281B2 (en) | 2016-09-08 | 2017-09-07 | Plant activator and a method of manufacturing the same |
PCT/JP2017/032354 Division WO2018047918A1 (en) | 2016-09-08 | 2017-09-07 | Plant activator and process for producing plant activator |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220295713A1 true US20220295713A1 (en) | 2022-09-22 |
Family
ID=61561487
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/331,300 Active 2039-03-02 US11382281B2 (en) | 2016-09-08 | 2017-09-07 | Plant activator and a method of manufacturing the same |
US17/832,837 Abandoned US20220295713A1 (en) | 2016-09-08 | 2022-06-06 | Plant activator and a method of manufacturing the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/331,300 Active 2039-03-02 US11382281B2 (en) | 2016-09-08 | 2017-09-07 | Plant activator and a method of manufacturing the same |
Country Status (5)
Country | Link |
---|---|
US (2) | US11382281B2 (en) |
EP (1) | EP3510868A4 (en) |
JP (3) | JPWO2018047918A1 (en) |
CN (1) | CN109688821A (en) |
WO (1) | WO2018047918A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11382281B2 (en) * | 2016-09-08 | 2022-07-12 | Ibiden Co., Ltd. | Plant activator and a method of manufacturing the same |
WO2018168582A1 (en) * | 2017-03-14 | 2018-09-20 | イビデン株式会社 | Pesticide and method for producing pesticide |
JPWO2018168581A1 (en) * | 2017-03-14 | 2020-05-14 | イビデン株式会社 | Pest repellent and method for producing pest repellent |
EP3597039B1 (en) | 2017-03-14 | 2024-05-01 | Ibiden Co., Ltd. | Plant activator |
US11317568B2 (en) | 2017-03-14 | 2022-05-03 | Ibiden Co., Ltd. | Agent for increasing a plant functional component content and a method of manufacturing the same |
JP7088694B2 (en) * | 2018-03-06 | 2022-06-21 | イビデン株式会社 | A method for producing a carrot growth promoter and a functional ingredient content improver in carrots, and a carrot growth promoter and a functional ingredient content improver in carrots. |
JP7088695B2 (en) * | 2018-03-06 | 2022-06-21 | イビデン株式会社 | Method for producing functional ingredient content improving agent in licorice and functional ingredient content improving agent in licorice |
JP6786746B2 (en) * | 2018-09-10 | 2020-11-18 | イビデン株式会社 | Plant functional ingredient enhancer |
JP7382053B2 (en) * | 2018-10-25 | 2023-11-16 | 学校法人 龍谷大学 | Root system formation promoter |
CN116471935A (en) | 2021-05-07 | 2023-07-21 | 揖斐电株式会社 | Plant activator |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11317568B2 (en) * | 2017-03-14 | 2022-05-03 | Ibiden Co., Ltd. | Agent for increasing a plant functional component content and a method of manufacturing the same |
US11382281B2 (en) * | 2016-09-08 | 2022-07-12 | Ibiden Co., Ltd. | Plant activator and a method of manufacturing the same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH066523B2 (en) * | 1990-01-24 | 1994-01-26 | 栃木県 | New microorganism |
JPH0680530A (en) | 1992-09-01 | 1994-03-22 | Mitsui Toatsu Chem Inc | Method for controlling disease damage of plant |
JP3639875B2 (en) * | 1993-04-27 | 2005-04-20 | 株式会社ビスタ | Plant growth regulator treated with active oxygen group, its production method and its use |
JPH0748218A (en) | 1993-08-03 | 1995-02-21 | B N Yuki Nouhou Kenkyusho:Kk | Method for controlling plant blight |
SE502660C2 (en) | 1994-04-18 | 1995-12-04 | Svenska Lantmaennen Riksfoerbu | Strain of Pseudomonas chlororapis capable of producing antipathogenically active metabolites, composites thereof, and method thereof for control of plant diseases |
JP3473228B2 (en) * | 1995-11-09 | 2003-12-02 | Nok株式会社 | Orchid cultivation promoter |
WO1998051155A1 (en) | 1997-05-09 | 1998-11-19 | Hiroshi Kawai | Method of preventing plant diseases and composition therefor |
ES2161146B1 (en) * | 1999-06-29 | 2002-07-01 | Consejo Superior Investigacion | Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids |
DE60009311T2 (en) | 1999-08-23 | 2005-02-17 | Shiseido Co. Ltd. | POTENTIATOR FOR PLANTS |
JP3571626B2 (en) | 1999-08-23 | 2004-09-29 | 株式会社資生堂 | Plant activator |
KR100587447B1 (en) | 2004-03-24 | 2006-06-12 | 한국화학연구원 | 120 bacillus subtilis eb120 strain microorganism formulation for controlling plant diseases containing same and method for controlling plant diseases using same |
CN101167480A (en) | 2006-10-23 | 2008-04-30 | 黄永 | Composite preparation made from microorganism fermented liquid |
CN104178537A (en) * | 2014-08-27 | 2014-12-03 | 齐鲁工业大学 | Sophorolipid agricultural antibiotic and application thereof to control of fungal diseases of crops |
KR20190095958A (en) * | 2017-01-06 | 2019-08-16 | 로커스 아이피 컴퍼니 엘엘씨 | New Fermentation Systems and Methods |
-
2017
- 2017-09-07 US US16/331,300 patent/US11382281B2/en active Active
- 2017-09-07 EP EP17848856.5A patent/EP3510868A4/en active Pending
- 2017-09-07 CN CN201780054954.2A patent/CN109688821A/en active Pending
- 2017-09-07 JP JP2018538473A patent/JPWO2018047918A1/en not_active Withdrawn
- 2017-09-07 WO PCT/JP2017/032354 patent/WO2018047918A1/en unknown
-
2020
- 2020-04-17 JP JP2020074163A patent/JP2020122000A/en active Pending
-
2022
- 2022-06-06 US US17/832,837 patent/US20220295713A1/en not_active Abandoned
- 2022-07-12 JP JP2022111836A patent/JP2022140478A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11382281B2 (en) * | 2016-09-08 | 2022-07-12 | Ibiden Co., Ltd. | Plant activator and a method of manufacturing the same |
US11317568B2 (en) * | 2017-03-14 | 2022-05-03 | Ibiden Co., Ltd. | Agent for increasing a plant functional component content and a method of manufacturing the same |
Also Published As
Publication number | Publication date |
---|---|
EP3510868A1 (en) | 2019-07-17 |
US20200060100A1 (en) | 2020-02-27 |
JP2022140478A (en) | 2022-09-26 |
CN109688821A (en) | 2019-04-26 |
EP3510868A4 (en) | 2020-04-08 |
JP2020122000A (en) | 2020-08-13 |
US11382281B2 (en) | 2022-07-12 |
WO2018047918A1 (en) | 2018-03-15 |
JPWO2018047918A1 (en) | 2019-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220295713A1 (en) | Plant activator and a method of manufacturing the same | |
US20220408728A1 (en) | Plant activator | |
García et al. | Effect of inoculation of Bacillus licheniformis on tomato and pepper | |
Liu et al. | Effect of IAA produced by Klebsiella oxytoca Rs-5 on cotton growth under salt stress | |
RU2689608C2 (en) | Isolated clonostachys rosea strain for use as a biological protection agent | |
JP5714603B2 (en) | Novel fluorescent Pseudomonas species of the Pseudomonas azotoformans species for enhancing budding and growth of plants | |
Lutz et al. | Lactic acid bacteria as biocontrol agents of soil-borne pathogens | |
Gusmiaty et al. | Gibberellin and IAA production by rhizobacteria from various private forest | |
JP2016534737A5 (en) | ||
JP7354382B2 (en) | Tomato fruit growth promoter and functional component content improver in tomato fruit, and method for producing tomato fruit growth promoter and functional component content improver in tomato fruit | |
CA2535766C (en) | Suppressing plant pathogens and pests with applied or induced auxins | |
Horotan et al. | Effects of fungicide and acetylsalicylic acid treatments on the physiological and enzymatic activity in tomato (Lycopersicon esculentum Mill.) | |
JP2010143881A (en) | New fungus-containing composition having plant disease control effect | |
JP2021143170A (en) | Plant activator | |
WO2022234663A1 (en) | Plant activator | |
JP2005137330A (en) | Agent for controlling disease injury of plant of family cruciferae and controlling method | |
JP2010053104A (en) | Agent and method for inhibiting germ infection of vegetable | |
WO2018168581A1 (en) | Insect repellent and method for producing insect repellent | |
WO2012120604A1 (en) | Growth regulation agent for plants, growth regulation method for plants and use of same | |
WO2018168582A1 (en) | Pesticide and method for producing pesticide | |
JP2022035344A (en) | Water culture device | |
Park | Application of Bacillus Mediated ISR Against Multiple Plant Pathogens and its Mode of Action | |
Olson et al. | New Tactics for Bacterial Wilt Management on Tomatoes in the Southern US | |
JPH08268826A (en) | Wilt disease control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |